NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

JTORENCE,

There are two upcoming conferences where Northwest Biotherapeutics is scheduled to participate—BNOS in July and CNS in September.

Conferences convened by world-renowned organizations such as ASCO, SNO, BNOS, NYAS, or CNS are never “nothing burgers” and conferences are never about any single company or any single presentation.

These events are global snapshots in time of the state of cancer care and new discovery. Medical conferences provide a glimpse, in momentary still frame, of the ever-evolving science toward better technologies and the future of oncology.

NWBO fits in the picture frame of world-renowned oncology conferences beautifully.

These events overall give some context to the emerging field of cell-based science and the future of cancer care. FDA officials are embracing the swift evolution of the science toward cell-based therapies and FDA officials are usually in attendance at global conferences.

Northwest Biotherapeutics is a small company on the cutting edge of science and innovation. The DCVax-L cell-based technology is on par with the biggest and best global blockbuster drugs. Consider the interim data of the pembrolizumab combo study at UCLA to illustrate why Northwest Biotherapeutics appears at worldwide conferences alongside companies like Merck and Bristol Myers Squibb.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172204891

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172194377